Universal influenza mRNA vaccine strategies include targeting conserved internal proteins (e.g., NP, M1, PB1) or combining multiple antigens from different subtypes (e.g., HA, NA, M2) to achieve broad cross-protection [92,93]. Here, XK is linked to influenza.